Howard Burt
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 7
-
- Pharmacogenetics and Drug Metabolism 8
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- J. Brian Houston (4 shared papers)Aleksandra Galetin (4 shared papers)Sibylle Neuhoff (4 shared papers)Laura E. Gibbons (1 shared paper)Matthew D. Harwood (2 shared papers)Arian Emami Riedmaier (2 shared papers)Amin Rostami‐Hodjegan (2 shared papers)Lisa M. Almond (2 shared papers)
- Journals
- Drug Metabolism and Disposition (4 papers)European Journal of Pharmaceutical Sciences (3 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)ACS Medicinal Chemistry Letters (1 paper)Xenobiotica (1 paper)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Howard Burt
16 papers receiving 590 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 337
- Oncology 306
- Pediatrics, Perinatology and Child Health 156
- Transplantation 19
- Computational Theory and Mathematics 79
Countries citing papers authored by Howard Burt
This map shows the geographic impact of Howard Burt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Burt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Burt more than expected).
Fields of papers citing papers by Howard Burt
This network shows the impact of papers produced by Howard Burt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Burt. The network helps show where Howard Burt may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard Burt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 122 | |
| 2 | 2019 | 110 | |
| 3 | 2016 | 97 | |
| 4 | 2016 | 59 | |
| 5 | 2007 | 52 | |
| 6 | 2013 | 37 | |
| 7 | 2010 | 31 | |
| 8 | 2016 | 21 | |
| 9 | 2018 | 19 | |
| 10 | 2021 | 16 | |
| 11 | 2012 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 1955 | 3 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Howard Burt
Howard Burt is a scholar working on Oncology, Pharmacology, Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmacology, having authored 18 papers that have together received 606 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (5 papers), Analytical Methods in Pharmaceuticals (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Computational Drug Discovery Methods (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Pharmacology (337 citations), Oncology (306 citations), Pediatrics, Perinatology and Child Health (156 citations), Transplantation (19 citations) and Computational Theory and Mathematics (79 citations). Howard Burt has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include J. Brian Houston, Aleksandra Galetin, Sibylle Neuhoff, Laura E. Gibbons, Matthew D. Harwood, Arian Emami Riedmaier, Amin Rostami‐Hodjegan, Lisa M. Almond, K Rowland‐Yeo and Lu Gaohua. Their work appears in journals such as Drug Metabolism and Disposition, European Journal of Pharmaceutical Sciences, CPT Pharmacometrics & Systems Pharmacology, ACS Medicinal Chemistry Letters and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.